Healthcare101

 The global hemodialysis and peritoneal dialysis market , valued at $92.0 billion in 2024, is projected to reach $126.2 billion by 2029, growing at a CAGR of 6.5%. This growth is driven by the rising prevalence of chronic kidney disease (CKD), particularly due to aging populations and increasing rates of diabetes and hypertension. Technological advancements, patient preference for home dialysis, and supportive reimbursement policies are key factors boosting market demand. However, complications linked to dialysis procedures and product recalls pose challenges. The market offers significant opportunities in emerging regions like China, India, and Brazil, where healthcare spending is increasing. Key players include Fresenius Medical Care, Baxter International, and DaVita Inc., and recent developments such as acquisitions and partnerships are enhancing market capabilities. North America is expected to maintain the largest market share due to its advanced healthcare infrastructure and ...

  Organ-on-Chip Market in terms of revenue was estimated to be worth $123,285 thousand in 2024 and is poised to reach $631,073 thousand by 2029, growing at a CAGR of 38.6% from 2024 to 2029 according to a new report by MarketsandMarkets™. Growth in the organ-on-chip market is mainly driven by factors such as growing emphasis on animal free drug testing, and an increase in the adoption of organ-on-chip technology by pharma and biotech companies for drug discovery and development. However, due to the limited scalability and low throughput of the current organ-on-chip technology, the use of this technology is restricted only to the pre-clinical drug development phase. Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144117291 Browse in-depth TOC on “Organ-on-Chip Market” 396 — Tables 38 — Figures 352 — Pages Disease-based model subsegment is the fastest-growing of the organ-on-chip market by model type Among the model type subsegments, the ma...

 The global healthcare information exchange (HIE) market , valued at US$1.5 billion in 2023 , rose to US$1.7 billion in 2024 and is projected to advance at a robust CAGR of 10.2% from 2024 to 2029 , reaching an estimated US$2.8 billion by the end of the forecast period. This growth underscores the increasing importance of seamless data sharing, interoperability, and digitization in modern healthcare systems. The comprehensive research on this market includes an in-depth analysis of pricing trends, patent activity, technological innovations, and strategic initiatives shaping the global HIE ecosystem. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=249987292 Key Growth Drivers The expansion of the healthcare information exchange market is primarily driven by the increasing emphasis on population health management , value-based care models , and regulatory mandates promoting electronic health record (EHR) adoption. Additionally, governments an...

 The 3D bioprinting market is experiencing significant growth, driven by technological advancements and increasing adoption across pharmaceutical and cosmetic industries. Valued at approximately USD 1.2 billion in 2023, the market is projected to reach USD 2.4 billion by 2029, with a compound annual growth rate (CAGR) of 12.7% Download PDF Brochure Key Market Drivers Technological Advancements: Innovations in 3D bioprinting technologies, such as the development of advanced bioinks and bioprinters, have enhanced the precision and efficiency of tissue fabrication. These advancements enable the creation of complex tissue structures, facilitating more accurate drug testing and disease modeling. Pharmaceutical and Cosmetic Industry Adoption: The pharmaceutical sector utilizes 3D bioprinting for drug discovery and development, allowing for the creation of tissue models that closely mimic human physiology. Similarly, the cosmetic industry employs bioprinted skin tissues for produ...

 The global Empty Capsules Market , valued at US$3.05 billion in 2024, stood at US$3.19 billion in 2025 and is projected to advance at a resilient CAGR of 5.6% from 2025 to 2030, culminating in a forecasted valuation of US$4.19 billion by the end of the period. The empty capsules market is propelled by increasing demand for nutraceuticals and personalized supplements, expansion in pharmaceutical R&D, and innovations in functional and modified-release capsules. A significant shift toward vegetarian and clean-label options, combined with sustainability-driven regulations, is further accelerating adoption. Future growth is anticipated from localized production in emerging markets and the creation of biodegradable capsules. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=218018190 Browse in-depth TOC on “Empty Capsules Market” 356 — Tables 48 — Figures 459 — Pages By functionality, the empty capsules market is categorized into immediate-release capsul...

  AI in Precision Medicine Market worth $3.92 billion by 2030 The report “ AI in Precision Medicine Market by Application (Drug Discovery, Screening, Diagnosis, Stratification, Staging, Prognosis, Therapy Selection, Monitoring, Risk Management), Indication (Cancer, CNS, CVS), Tools (ML, NLP), & End User -Global Forecast to 2030” , is projected to reach USD 3.92 billion by 2030 from USD 0.78 billion in 2024, at a CAGR of 30.7% from 2024 to 2030. Several factors propelling the expansion of AI technologies in precision medicine are in tune with the availability of advanced technologies and the rising need for personalized patient care. To begin with, there is a massive collection of data types in terms of genomics, proteomics, and metabolomics, which AI performs and extracts disease biomarkers and variants. For instance, Google’s DeepVariant can optimize genomic sequencing accuracy with the power of AI, facilitating targeted treatment models. Additionally, there is also a tr...